Piramal Enterprises is currently trading at Rs. 1929.50, up by 49.35 points or 2.62% from its previous closing of Rs. 1880.15 on the BSE.
The scrip opened at Rs. 1879.70 and has touched a high and low of Rs. 1940.40 and Rs. 1838.05 respectively. So far 103522 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 3302.55 on 31-Aug-2018 and a 52 week low of Rs. 1706.10 on 20-Jun-2019.
Last one week high and low of the scrip stood at Rs. 2128.65 and Rs. 1706.10 respectively. The current market cap of the company is Rs. 37925.01 crore.
The promoters holding in the company stood at 49.70%, while Institutions and Non-Institutions held 33.13% and 17.17% respectively.
Piramal Pharma Solutions, the Contract Development and Manufacturing arm of Piramal Enterprises, has invested $10 million to expand its high-potency active pharmaceutical ingredients (HPAPIs) facility in the US. The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OEL).
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
